Faron Pharmaceuticals Limited (AIM:FARN) has repaid €1.6 million of debt owed to its convertible bondholder by issuing 3.4 million new shares rather than paying cash. New shares were issued for €0.4741 per share. They are due to begin trading on AIM and Nasdaq First North on 4 June.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com